Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome.

Auld SC, Maenetje P, Ravimohan S, Weissman D, Ncube I, Mlotshwa M, Ratsela N, Chase W, Vangu MD, Wallis R, Churchyard G, Kornfeld H, Bisson GP.

Clin Infect Dis. 2019 Sep 25. pii: ciz733. doi: 10.1093/cid/ciz733. [Epub ahead of print]

PMID:
31552412
2.

Lung injury on antiretroviral therapy in adults with HIV/TB.

Ravimohan S, Auld SC, Maenetje P, Ratsela N, Mlotshwa M, Ncube I, Smith JP, Vangu MD, Sebe M, Kossenkov A, Weissman D, Wallis RS, Churchyard G, Kornfeld H, Bisson GP.

Clin Infect Dis. 2019 Jun 26. pii: ciz560. doi: 10.1093/cid/ciz560. [Epub ahead of print]

PMID:
31242296
3.

HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa.

Maenetje P, Lindan C, Makkan H, Chetty-Makkan CM, Latka MH, Charalambous S, Mlotshwa M, Malefo M, Brumskine W, Hills NK, Price MA, Edward V.

PLoS One. 2019 Apr 3;14(4):e0214786. doi: 10.1371/journal.pone.0214786. eCollection 2019.

4.

Predictors of male condom use among sexually active heterosexual young women in South Africa, 2012.

Ntshiqa T, Musekiwa A, Mlotshwa M, Mangold K, Reddy C, Williams S.

BMC Public Health. 2018 Sep 24;18(1):1137. doi: 10.1186/s12889-018-6039-8.

5.

Evaluating the electronic tuberculosis register surveillance system in Eden District, Western Cape, South Africa, 2015.

Mlotshwa M, Smit S, Williams S, Reddy C, Medina-Marino A.

Glob Health Action. 2017;10(1):1360560. doi: 10.1080/16549716.2017.1360560.

6.

Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.

Mlotshwa M, Abraham N, Beery M, Williams S, Smit S, Uys M, Reddy C, Medina-Marino A.

BMC Infect Dis. 2016 Aug 2;16:365. doi: 10.1186/s12879-016-1712-y.

7.

Ileosigmoid knotting in early pregnancy: A case report.

Maunganidze AJ, Mungazi SG, Siamuchembu M, Mlotshwa M.

Int J Surg Case Rep. 2016;23:20-2. doi: 10.1016/j.ijscr.2016.03.022. Epub 2016 Apr 5.

8.

HIV prevalence among high school learners - opportunities for school-based HIV testing programmes and sexual reproductive health services.

Kharsany AB, Mlotshwa M, Frohlich JA, Zuma NY, Samsunder N, Karim SS, Karim QA.

World Health Popul. 2012;13(4):43-50.

PMID:
23089727
9.

Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression.

Ntale RS, Chopera DR, Ngandu NK, Assis de Rosa D, Zembe L, Gamieldien H, Mlotshwa M, Werner L, Woodman Z, Mlisana K, Abdool Karim S, Gray CM, Williamson C; CAPRISA 002 Study Team.

J Virol. 2012 Nov;86(22):12013-24. doi: 10.1128/JVI.00539-12. Epub 2012 Aug 29.

10.

HIV incidence in young girls in KwaZulu-Natal, South Africa--public health imperative for their inclusion in HIV biomedical intervention trials.

Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mlotshwa M, Madlala BT, Abdool Karim SS.

AIDS Behav. 2012 Oct;16(7):1870-6.

11.

HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services.

Kharsany AB, Mlotshwa M, Frohlich JA, Yende Zuma N, Samsunder N, Abdool Karim SS, Abdool Karim Q.

BMC Public Health. 2012 Mar 22;12:231. doi: 10.1186/1471-2458-12-231.

12.

Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.

Riou C, Ganusov VV, Campion S, Mlotshwa M, Liu MK, Whale VE, Goonetilleke N, Borrow P, Ferrari G, Betts MR, Haynes BF, McMichael AJ, Gray CM.

J Immunol. 2012 Mar 1;188(5):2198-206. doi: 10.4049/jimmunol.1102813. Epub 2012 Jan 27.

13.

Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals.

Chopera DR, Mlotshwa M, Woodman Z, Mlisana K, de Assis Rosa D, Martin DP, Abdool Karim S, Gray CM, Williamson C; CAPRISA 002 Study Team.

J Virol. 2011 Jul;85(14):7070-80. doi: 10.1128/JVI.02543-10. Epub 2011 May 25.

14.

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.

Karim QA, Kharsany AB, Frohlich JA, Baxter C, Yende N, Mansoor LE, Mlisana KP, Maarschalk S, Arulappan N, Grobler A, Sibeko S, Omar Z, Gengiah TN, Mlotshwa M, Samsunder N, Karim SS.

Trials. 2011 Mar 7;12:67. doi: 10.1186/1745-6215-12-67.

15.

Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.

Karim QA, Kharsany AB, Frohlich JA, Werner L, Mashego M, Mlotshwa M, Madlala BT, Ntombela F, Abdool Karim SS.

Int J Epidemiol. 2011 Aug;40(4):922-30. doi: 10.1093/ije/dyq176. Epub 2010 Nov 3.

16.

Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression.

Mlotshwa M, Riou C, Chopera D, de Assis Rosa D, Ntale R, Treunicht F, Woodman Z, Werner L, van Loggerenberg F, Mlisana K, Abdool Karim S, Williamson C, Gray CM; CAPRISA 002 Study Team.

J Virol. 2010 Nov;84(22):12018-29. doi: 10.1128/JVI.01472-10. Epub 2010 Sep 8.

17.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group.

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29;333(6042):524.

18.

Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point.

Burgers WA, Riou C, Mlotshwa M, Maenetje P, de Assis Rosa D, Brenchley J, Mlisana K, Douek DC, Koup R, Roederer M, de Bruyn G, Karim SA, Williamson C, Gray CM; CAPRISA 002 Acute Infection Study Team.

J Immunol. 2009 Apr 15;182(8):4751-61. doi: 10.4049/jimmunol.0803801.

19.

Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point.

Gray CM, Mlotshwa M, Riou C, Mathebula T, de Assis Rosa D, Mashishi T, Seoighe C, Ngandu N, van Loggerenberg F, Morris L, Mlisana K, Williamson C, Karim SA; CAPRISA 002 Acute Infection Study Team.

J Virol. 2009 Jan;83(1):470-8. doi: 10.1128/JVI.01678-08. Epub 2008 Oct 22.

20.

Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.

Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, Seoighe C, Treurnicht F, de Rosa DA, Hide W, Karim SA, Gray CM, Williamson C; CAPRISA 002 Study Team.

PLoS Pathog. 2008 Mar 21;4(3):e1000033. doi: 10.1371/journal.ppat.1000033.

Supplemental Content

Loading ...
Support Center